Sleep disordered breathing and metabolic syndrome

Sleep disordered breathing and metabolic syndrome

Sleep disordered breathing (SDB) has been associated with cardiovascular disease, hypertension, and insulin resistance. This article examines the association between SDB and the prevalence of metabolic syndrome (MS) in a community-based sample. A subset of participants in the Wisconsin Sleep Cohort...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Wisconsin medical journal (Madison, Wis.) Wis.), 2009-08, Vol.108 (5), p.263-265
Hauptverfasser: Nieto, F Javier, Peppard, Paul E, Young, Terry B
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Aged
Chi-Square Distribution
Cohort Studies
Female
Humans
Insulin Resistance
Logistic Models
Male
Metabolic Syndrome - epidemiology
Middle Aged
Polysomnography
Risk Factors
Sleep Apnea Syndromes - epidemiology
Wisconsin - epidemiology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Sleep disordered breathing (SDB) has been associated with cardiovascular disease, hypertension, and insulin resistance. This article examines the association between SDB and the prevalence of metabolic syndrome (MS) in a community-based sample. A subset of participants in the Wisconsin Sleep Cohort Study (N=546) participated in an ancillary study to measure vascular and metabolic function. SDB was characterized using the apnea-hypopnea index (AHI) obtained in the polysomnography study closest to the collection of the metabolic measures. MS was defined using the National Cholesterol Education Program definition, and the homeostasis model assessment method (HOMA) was used to characterize insulin resistance. SDB was significantly correlated with insulin resistance (Spearman r correlation between AHI and HOMA=0.30, P
ISSN:1098-1861